4basebio Achieves GMP Certification for UK DNA Facility

4basebio UK Societas ( (GB:4BB) ) has provided an announcement.

4basebio has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare Products Regulatory Agency for its DNA manufacturing facility in Cambridge. This certification allows the company to manufacture and supply investigational medicinal products and critical starting materials for advanced therapy medicinal products, marking a significant milestone in its operations. The achievement enhances 4basebio’s standing in the field of advanced therapeutics and supports its goals of product commercialization and improved patient care.

More about 4basebio UK Societas

4basebio is an innovation-driven biotechnology company focused on accelerating the development of advanced therapy medicinal products (ATMPs). The company specializes in high-performance synthetic DNA products and a non-viral, cell-targeting nucleic acid delivery platform, aiming to become a leader in the manufacture and supply of high-quality synthetic DNA for research, therapeutic, and pharmacological use.

YTD Price Performance: -3.72%

Average Trading Volume: 753

Technical Sentiment Signal: Hold

Current Market Cap: £174.8M

See more data about 4BB stock on TipRanks’ Stock Analysis page.